GoodRx, an online drug price comparison platform, excluded drugs that have to be administered by a healthcare provider and obtained typical fill quantities from drugmaker websites to compare the monthly prices.
Many of the drugs on this year’s list are the same as in 2019, but the most expensive drugs are even more expensive now. Last year’s most expensive drug was $52,322 per month.
The 20 most expensive drugs based on their monthly list prices:
- Myalept — $71,306 (Amryt Pharma)
- Ravicti — $55,341 (Horizon Therapeutics)
- Mavenclad — $53,730 (EMD Serono)
- Actimmune — $52,777 (Horizon Therapeutics)
- Oxervate — $48,498 (Dompé)
- Takhzyro — $45,464 (Takeda)
- Daraprim — $45,000 (Vyera Pharmaceuticals)
- Juxtapid — $44,714 (Amryt Pharma)
- Cinryze — $44,141 (Takeda)
- Chenodal — $42,570 (Retrophin)
- Gattex — $40,450 (Takeda)
- H.P. Acthar — $39,864 (Mallinckrodt Pharmaceuticals)
- Tegsedi — $34,600 (Akcea Therapeutics)
- Vitrakvi — $32,800 (Bayer Pharmaceuticals)
- Ayvakit — $32,000 (Blueprint Medicines)
- Kynamro — $30,444 (Kastle Therapeutics)
- Sovaldi — $28,000 (Gilead)
- Viekira Pak — $27,773 (AbbVie)
- Viekira XR — $27,773 (AbbVie)
- Tibsovo — $27,421 (Agios Pharmaceuticals)
More articles on pharmacy:
Why physicians are fighting BCBS plan requiring use of mail-order pharmacies
Foreign governments are using US research, manipulating drug prices, White House study claims
Chain drugstores under probe in Oklahoma after claims of inadequate pharmacy staffing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
